Multiple sclerosis (MS) is characterized by chronic inflammation leading to central nervous system demyelination. Almost 90% of people with MS have relapsing-remitting MS (RRMS) or secondary ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

Similarly, the therapy led to long-term reductions of severe symptoms of 91% and 100% for the smaller and larger doses, ...

In a paper published in Science Bulletin, multi-omics analyses comprising of lipidomics (439 lipids), sterolomics (22 ...

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers of multiple sclerosis progression.

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS ...

The complex relationship between possibly impaired cognitive function in patients with multiple sclerosis (MS) and fasting ...

New research has identified crucial links between dietary choices and the progression of multiple sclerosis (MS). The study explored how enzymes called ceramide synthase 5 and 6 are responsible for ...

Model developed in study will pave way for more discovery about important but mysterious process Ben Emery, Ph.D., and ...

Neuroprotective effect of neuron-specific deletion of the C16 ceramide synthetic enzymes in an animal model of multiple ...

According to the National Multiple Sclerosis Society, numbness is one of the most common symptoms of the disease. Another person who was diagnosed with MS said their thighs would feel like they were ...

Multiple sclerosis (MS) is an inflammatory disease in which the immune system attacks the central nervous system. The molecular mechanisms underlying this disease remain poorly understood. In ...